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Available online 1 March 2010AbstractIn animal trypanosomiasis the severity of infection is reflected by the degree of anemia which resembles anemia of inflammation, involving
a skewed iron homeostasis leading to iron accumulation within the reticuloendothelial system. Myeloid cells (M cells) have been implicated in
the induction and maintenance of this type of anemia and modulation of M cells through the main trypanosome-derived glyco-
sylphosphatidylinositol (GPI)-anchor could attenuate both anemia and trypano-susceptibility in Trypanosoma brucei-infected mice. Herein the
GPI-based treatment, allowing a straightforward comparison between trypanotolerance and susceptibility in T. brucei-infected C57Bl/6 mice,
was further adopted to scrutinize mechanisms/pathways underlying trypanosome-elicited anemia. Hereby, the following interlinkable obser-
vations were made in GPI-based treated (GBT) T. brucei-infected mice: (i) a reduced inflammatory cytokine production and increased IL-10
production associated with alleviation of anemia and restoration of serum iron levels, (ii) a shift in increased liver expression of iron storage
towards iron export genes, (iii) increased erythropoiesis in the bone marrow and extramedullar sites (spleen) probably reflecting a normalized
iron homeostasis and availability. Collectively, our results demonstrate that reprogramming macrophages towards an anti-inflammatory state
alleviates anemia of inflammation by normalizing iron homeostasis and restoring erythropoiesis.
 2010 Elsevier Masson SAS. All rights reserved.
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Anemia of inflammation also termed anemia of chronic
disease (ACD) is the most frequent form of anemia amongAbbreviations: ACD, anemia of chronic disease; CP, ceruloplasmin; DMT-
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HAT, human African trypanosomiasis; He, heme; HO-1, heme oxygenase I;
M1, classically activated macrophages or caM4; M2, alternatively activated
macrophages or aaM4; NF-kB, nuclear factor kappa B; RBC, red blood cell;
Tf, transferrin; Tf-R, transferrin receptor; VSG, variant surface glycoprotein.
* Corresponding author. Department of Molecular and Cellular Interactions,
VIB, 1050 Brussel, Belgium. Tel.: þ32 2 629 1977; fax: þ32 2 629 1981.
E-mail address: bstijlem@vub.ac.be (B. Stijlemans).
1286-4579/$ - see front matter  2010 Elsevier Masson SAS. All rights reserved.
doi:10.1016/j.micinf.2010.02.006hospitalized patients and develops under chronic inflammatory
disorders such as chronic infections, cancer or autoimmune
diseases [1,2]. A number of different pathways contribute to
ACD, such as diversion of iron traffic, reduced erythropoiesis,
blunted responses to erythropoietin, enhanced erythro-
phagocytosis and bone marrow invasion by tumor cells and
pathogens [2]. ACD is the consequence of a persistent acti-
vated inflammatory immune response and is a defense strategy
of the body in order to withdraw the essential growth factor
iron from invading pathogens and to increase the efficacy of
cell-mediated immunity [1]. Hyperactivated-macrophages
were found to be key players in ACD by producing pro-
inflammatory cytokines and, therefore, may represent
a target for potential intervention strategies [1]. In order to
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we used an African trypanosomiasis model, since we recently
documented that the immunopathology occurring during
trypanosome infection resembles anemia of inflammation and
is associated with hyperactivated-macrophages [3].
African trypanosomiasis is a parasitic disease of medical
and veterinary importance that has adversely influenced the
economic development of sub-Saharan Africa [4,5]. The
causative agents, tsetse-transmitted trypanosomes, are extra-
cellular hemoflagellated protozoan parasites that cause fatal
diseases in mammals, commonly called sleeping sickness in
humans (HAT, Human African Trypanosomiasis) or nagana in
domestic livestock [5]. In case of bovine Trypanosomiasis,
caused by Trypanosoma brucei brucei, anemia is considered
to be the most prominent immunopathological disease-related
feature and the major cause of death associated with the
disease [6]. Important to mention is that trypanotolerance in
domestic livestock populations has been defined as the relative
capacity of an animal to (i) control parasite development and
(ii) to limit the pathological effects, i.e., anemia. The latter is
independent of parasitemia control, T-cells or antibodies
[6e10]. Interestingly, using different gene-deficient mice it
was found that in murine Trypanosoma brucei trypanosomi-
asis anemia does not correlate with parasite burden nor with
survival [11] similar to the bovine model [12]. In addition, it
was observed that trypanosusceptible animals exhibited severe
anemia development, whereas the more trypanotolerant
animals had significantly reduced anemia levels [11]. Conse-
quently, these murine model systems seem appropriate to
study the mechanisms underlying trypanosome-associated
anemia. So far, the experimental evidence points to a contri-
bution of the host immune, inflammatory responses to
trypanosome-elicited anemia during murine T. brucei infec-
tions since TNF, TNF-R2, IFN-g-R and MyD88 deficient
mice exhibit significantly lower levels of anemia as compared
to wild-type C57Bl/6 mice [13e15]. Therefore, it was sug-
gested that anemia development is a consequence of the host’s
inflammatory responses induced by the infection, rather than
a direct influence of parasite products. All data indicate that
the occurrence of classically activated macrophages (caM4 or
M1), needed for initial parasite control, can if maintained also
contribute to anemia development. Indeed, these M1 cells can
phagocytose, besides parasites, red blood cells (RBC)
(erythro-phagocytosis) and thereby could play a key role in
anemia development. Hereby, macrophage hyperactivation
was proposed to be involved in the extravascular destruction
of RBC due to enhanced erythrophagocytosis by spleen and
liver-associated M1 cells of trypanosome-infected host
(reviewed in [9]) and resulting in trypanosome-associated
anemia [16e20]. Such Type-1 cytokine driven anemia
resembles anemia of inflammation that is associated with
chronic infections and inflammations (reviewed in [2] and
[3]). In this context, we have shown that during T. brucei
infections serum iron levels decline and parallel anemia
develop [3]. Furthermore, gene expression analysis suggests
that there is diversion of iron from erythropoiesis to storage
sites within the reticuloendothelial system, which in turncould contribute to functional iron deficiency and conse-
quently to anemia of inflammation.
Therefore, given that M1 cells are implicated in the uptake
and processing of RBC through extreme M1 activation (host/
inflammation-elicited anemia), the activation state of M1
might represent a potential target for immune intervention, at
least as far as anemia development is concerned. In this
context, the glycosylphosphatidylinositol (GPI)-anchor of the
Variant Surface Glycoprotein coat (VSG) was found to be the
major parasite-derived molecule exhibiting a strong M1 acti-
vating potential [21e23]. Furthermore, using this VSGeGPI
moiety, a treatment modality was designed to counteract the
parasite-induced M1 activation, whereby mice were exposed
to trypanosome-derived GPI prior to an infectious trypano-
some challenge [24]. This GPI-based treatment resulted in
a significantly prolonged survival and substantial protection
against infection-associated weight loss, liver damage and
anemia [24]. The alleviation of anemia due to the GPI-based
treatment was found to be associated with a modulation of
the macrophage activation state, i.e., transition from M1
during the early stages of infection to M2 (alternatively acti-
vated macrophages or aaM4) during the later stages of
infection, rather than on the production of GPI-specific anti-
bodies [24,25].
Hence, thorough comparison of susceptible mice, i.e., wild-
type C57Bl/6 mice exhibiting severe anemia due to the pres-
ence of M1 cells, and more tolerant mice, i.e., GPI-based
treated (GBT) mice exhibiting reduced anemia levels associ-
ated with occurrence of M2 cells, provides an appropriate
model to study the molecular mechanisms/pathways that
directly or indirectly contribute to trypanosomiasis-associated
anemia. Indeed, rendering susceptible animals tolerant through
a GPI-based treatment offers the advantage that a comparison
can be made without having to take into account (i) the
differences in anemia development due to the genetic back-
ground of the mice and/or (ii) the differences in parasite
virulence/strain. We will herein document that alleviation of
anemia during trypanosome infection using a GPI-based
treatment coincides with a normalized iron homeostasis,
which in turn may restore erythropoiesis.
2. Materials and methods2.1. Trypanosome infectionsSix to eight weeks old female C57Bl/6 mice (Harlan) were
treated with empty liposomes (i.e., control) or GPI-containing
liposomes (i.e., GPI-based) (preparation of materials see [24])
prior to intraperitoneal (i.p.) infection with 5 103 pleomor-
phic AnTat1.1E T. brucei trypanosomes. Of note, the GPI-
based treatment consisted of injecting mice i.p. with 200 ml
of 8-mercaptoguanosine MG (30 mg/ml) 2 h before the
injection of 100 ml GPI liposomes (corresponding to
0.1e0.5 mg GPI). This was repeated twice with three weeks
interval. The control mice were treated as above with empty
liposomes. Parasite and RBC numbers (anemia) in blood were
determined via hematocytometer by tail-cut (2.5 ml blood in
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were done according to the guidelines of the Belgian Council
for Laboratory Animal Science (BCLAS).2.2. Measurement of serum iron and hemoglobin contentTotal serum iron was measured using the IRON FZ kit
(Chema Diagnostics) as recommended by the suppliers.
Hemoglobin in the serum was quantified colorimetrically.
Therefore, 2 ml blood was diluted in 200 ml distilled water in
a 96-well, round-bottom well plate (Falcon) and incubated for
30 min at 37 C. Next, the plate was centrifuged at 600g for
10 min after which the supernatant was transferred to a new
plate and the optical density measured at 540 nm in an Ultra
Microplate reader (ELx808, Bio-Tek Instruments, Inc.). The
concentration of hemoglobin was calculated from a known
amount of hemoglobin (sigma) assayed in parallel. The results
were expressed as mg Hb/dl. Each experiment corresponds to
3e5 mice and samples were measured in triplicate.2.3. Liver cell isolation protocolThe livers from CO2 euthanized non-infected and
trypanosome-infected (day 18 p.i.) C57Bl/6 control, GPI-
based treated (GBT) mice (3e5 mice/group), were perfused
with 30 ml heparinised saline (10 units/ml; Leo Pharma,
Ontario) containing collagenase (0.05%; type II from
Clostridium histolyticum; SigmaeAldrich, Ontario). The liver
was then quickly excised, rinsed in fresh saline and separated
from the gall bladder and connective tissue. Next, the liver was
cut with a razor blade and minced in a petri dish containing
10 ml digestive media [DNase I (0.002%; Grade I from bovine
pancreas; Roche, Que´bec) and collagenase (0.05%; type II
from C. histolyticum; SigmaeAldrich, Oakville, Ontario) in
Hanks’ Balanced Salt Solution (HBSS without calcium or
magnesium; Invitrogen, Ontario)] and incubated at 37 C for
30 min. The digested tissue was homogenized and passed
through a 40-mm pore filter with fresh sterile phosphate-
buffered saline (PBS) without calcium or magnesium
(pH 7.4). The cell suspension was then spun for 7 min, 300g,
at 4 C. After removal of the supernatant, residual red blood
cells were removed by hypotonic lysis. Briefly, the cells were
resuspended in 5 ml red blood cell lysis buffer (8.23 g NH4Cl,
1 g KHCO3 and 0.037 g EDTA) pH 7.4 and incubated on ice
for 2 min. Next, 45 ml RPMI/10% FCS was added and the cell
suspension was again spun for 7 min, 300g, at 4 C. Finally,
the pellet was resuspended in RPMI/10% FCS. For a total cell
count, a sample was diluted 1:10 in Trypan blue and mounted
on a haemocytometer.
Total liver cells, obtained as described above were brought
at a concentration of 107 cells/ml in RPMI/10% FCS and used
for RT-QPCR. Therefore, 107 cells were pelleted (1400 rpm,
10 min, 4 C) and subsequently resuspended in 1 ml TRIzol
reagent (Invitrogen) and stored at 80 C till further use.2.4. Spleen and bone marrow cell isolationThe spleens were taken from na€ıve, control and GBT
C57Bl/6 mice at day 18 p.i. and cells were obtained by
homogenizing the organs in a petri dish containing 10 ml
RPMI/10% FCS medium. Next, the suspension was passed
through a 40-mm pore filter and spun for 7 min, 300g, at 4 C.
For a total cell count, a sample was diluted 1:10 in Trypan blue
and mounted on a haemocytometer. The cells were brought at
a concentration of 107 cells/ml in RPMI/10% FCS medium for
further analysis via flow cytometry. The tibia and femur of
each group of mice were flushed and subsequently processed
as described for the spleen (see above).2.5. Cytokine measurementsConcentrations of TNF (R&D Systems), IFN-g, IL-6, and
IL-10 (Pharmingen) in serum were determined by sandwich
ELISA as recommended by the suppliers. Triplicates of each
sample were analysed.2.6. Real-time quantitative polymerase chain reaction
(RT-QPCR) analysisTotal RNAwas prepared using TRIzol reagent (Invitrogen
Life Technologies), and 1 mg total RNA was reverse-
transcribed using oligo(dT) (Invitrogen) and Superscript II
Reverse Transcriptase (Invitrogen) following the manufac-
turer’s recommendations. RT-QPCR was performed on an
iCycler apparatus (Biorad, Hercules, CA) using iQ SYBR
Green Supermix (Biorad). The PCR conditions were as
described in Raes et al. [26]. Briefly, the PCR consisted of
3 min denaturation at 95 C, followed by 40 cycles of 1 min
denaturation at 94 C, 45 s annealing at 55 C, and 1 min
extension at 72 C. Each reaction consisted of 15 ng template
(4 ml), 30 nM of each primer (1 ml), 12.5 ml iQ SYBR Green
Supermix and 6.5 ml autoclaved water was added to give
a final volume of 25 ml. The primer sequences (forward (F)
and reverse (R)) used are: HO-1 (Heme oxygenase I, Hmox-1)
F: 50-GACACCTGAGGTCAAGCACAG-30 and R: 50-CCAC
TGCCACTGTTGCCAAC-30; DMT-1 (natural resistance-
associated macrophage protein (Nramp-2)) F: 50-TCATG
GAGGGATTCCTGAAC-30 and R: 50-TCCTCCAGCCTAT
TCCATTG-30; FPN-1 (Ferroportin-1) F: 50-CCAGTCATT
GGCTGTGGTT T-30 and R: 50-AGGTGGGCTCTTGTTCA
CAT-30; FHC (Ferritin Heavy Chain) F: 50-GTCAGCTTAGC
TCTCATCAC-30 and R: 50-ACGTCTATCTGTCTATGTC
TTG-30; Transferrin (Tf) F: 50-TCAACCACTGCAAATTC
GATG-30 and R: 50-ACAGGCTTCCTGG TGCCATC-30;
Transferrin receptor 1 (Tf-R1) F: 50-GTTTCCGCCATCT
CAGTCAT-30 and R: 50-CAACATAACGGTCTGGTTCC-30.
Gene expression was normalized using ribosomal protein s12
as described in [26], to ensure that the observed differences in
the expression levels of each gene in different cells were not
a result of differences in the amount of template cDNA.
RT-QPCR on total liver cells was performed in duplicates. The
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Fig. 1. GPI-based treatment confers protection during T. brucei brucei infec-
tion. (a) Anemia development in GPI-based treated (GBT) (B) and control-
treated (C) mice during the course of T. brucei infection. Results are repre-
sentative of at least 3 independent experiments. (b) Serum cytokine levels of
IFN-g (upper left panel), TNF (upper right panel), IL-6 (lower left panel) and
IL-10 (lower right panel) of GBT (open bars) and control-treated (black bars)
mice at day 18 post-infection (p.i.). (c) Serum iron levels of GBT (open bars)
and control-treated (black bars) mice at day 18 p.i. (d) Serum hemoglobin
levels of GBT (open bars) and control-treated (black bars) mice at day 18 p.i.
Dashed lines represent infection parameters of na€ıve animals. Red circle
corresponds to the time-point of further analysis. Results are presented as
mean of 3 individual serum samples SD and the results are representative for
2 independent experiments. (*: p-values 0.05, **: p-values 0.01).Both control (i.e., mock-treated) and GPI-based treated
(GBT) C57BL/6 mice were inoculated i.p. with 5000 pleo-
morphic T. brucei parasites and RBC counts were monitored
during the course of infection. Both groups of mice exhibited
an initial sharp drop in RBC counts during the early phase of
infection (6e8 days p.i.), which was more severe in the control
C57Bl/6 group (Fig. 1a, black dots) as compared to GBT
C57Bl/6 mice (Fig. 1a, white dots). This was followed by
a recovery phase (day 9e10 p.i.) occurring in both mice
groups. From day 12 p.i. onward, the control mice revealed
a gradual decrease in RBC counts, which was maintained
during the chronic phase of T. brucei infection. In contrast, the
GBT mice exhibited a delayed anemia development during
later stages of infection as compared to control mice.
In subsequent experiments, infection parameters were
analysed at day 18 p.i. (see red circle in Fig. 1a), when the
differences in anemia development between control and GBT
mice were most pronounced. First, since anemia development
may be due to inflammatory immune responses mounted
during the course of infection, the dissimilarity in anemia
development between both mice groups could be attributed to
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393B. Stijlemans et al. / Microbes and Infection 12 (2010) 389e399differences in inflammatory responses. Therefore, the inflam-
matory serum cytokine levels (TNF, IFN-g and IL-6) were
determined in both groups of mice and found to be elevated in
the trypanosusceptible animals, i.e., control C57Bl/6 mice
(Fig. 1b, black bars). In contrast, the inflammatory serum
cytokine levels were significantly reduced in the more tolerant
animals, i.e., GBT mice, as compared to the susceptible
animals. Furthermore, IL-10 serum levels increased signifi-
cantly in the more tolerant animals. Secondly, since RBC are
the main transporters of iron, the iron content in the sera was
also monitored and as shown in Fig. 1c (bottom left panel), the
iron levels in the susceptible mice decreased during infection
(day 18 p.i.), indicating an impaired iron metabolism.
However, the serum iron levels of the more tolerant animals
were not impaired during infection. Third, given that iron is an
essential part of hemoglobin, the major component of RBC,
the hemoglobin levels were measured in both groups of
T. brucei-infected animals. The results presented in Fig. 1d
(bottom right panel) show that the susceptible mice had
reduced hemoglobin levels as compared to the more tolerant
mice, whose levels remain similar to those of uninfected
animals. Of note, none of the infection parameters presented
here was affected by the treatment alone in the absence of
infection (data not shown).b
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Fig. 2. Effect of the GPI-based treatment on the expression of genes involved
in iron metabolism. (a) The expression of HO-1 (Heme catabolism, upper left),
DMT-1 (transport, upper right), FHC (storage, middle left) and FPN-1 (export,
middle right) was quantified by RT-PCR in total livers from GBT (open bars)
and control-treated (black bars) mice at day 18 p.i. (b) The expression of
transferrin (transport, lower left) and Tf-R1 (transport/uptake, lower right).
Gene expression levels are normalized using s12 and against levels of naive
mice. For each experiment a pool of 3 mice was used and the results are
representative for 2 independent experiments. (*: p-values 0.05, **:
p-value 0.01).Following uptake of RBC or iron-containing components
by macrophages, hemoglobin is degraded and iron is released
from heme (He) through the action of heme oxygenase I
(HO-1), the rate limiting enzyme of He degradation [27,28],
resulting in the release of ferrous iron (Fe2þ). Next, iron is
transported into the cytosol via the divalent metal transporter-1
(DMT-1), from where it can either be exported via ferroportin-
1 (FPN-1) or stored inside the cell by ferritin (FHC).
Therefore, the expression of these genes implicated in iron
metabolism was analysed during T. brucei infection in both
control and GBT mice.
The results shown in Fig. 2a reveal that the liver gene
expression levels of HO-1, DMT-1 and FHC in control,
infected mice are significantly increased at day 18 post-
infection (Fig. 2a, black bar). In contrast, the gene expres-
sion levels of HO-1, DMT-1 and FHC are significantly lower
in GBT-infected mice, indicating that in these mice (Fig. 2a,
white bar) there is a reduced uptake as well as a reduced
accumulation of iron as compared to control-infected mice.
Furthermore, it was observed that the FPN-1 mRNA levels
increased also, albeit moderately, in infected control mice
(Fig. 2a, black bar in lower panel) and was significantly higher
in infected GBT mice (Fig. 2a, white bar in lower panel),
suggesting that in the GBT mice iron export is less impaired as
compared to control mice.
The observation that GBT mice exhibit reduced modulation
of genes involved in iron homeostasis could be due to differ-
ences in uptake of senescent or modified RBC (via Fcg-R andCD36, respectively) as well as to differences in expression of
receptors involved in uptake of iron-containing molecules like,
transferrin receptor 1 or 2 (Tf-R1 or Tf-R2, uptake of iron-
bound transferrin), CD163 (uptake of hemoglobinehapto-
globin) and CD91 (uptake of HemeeHemopexin). In fact as
documented before [3], the gene expression levels of these
receptors were modulated during the chronic phase of
T. brucei infections. Therefore, the expression level of these
genes was compared between control and GBT mice in total
liver cells during T. brucei infection (day 18 p.i.). Though the
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the infection, there was no significant difference in gene
expression levels for Fcg-R, CD36, CD163, CD91 and Tf-R2,
between control and GB-infected mice (data not shown).
In case of Tf-R1, the expression level was found to be
significantly reduced ( p-value: 0.033) in infected GBT mice
as compared to control mice (Fig. 2b, right panel). Further-
more, the expression levels of transferrin (Tf), the universal
transporter of iron to all cells of the immune system, that were
significantly reduced during infection in control mice, were
restored in infected GBT mice (Fig. 2b, left panel).3.3. GPI-based treatment alleviates suppression at the
level of erythropoiesisIn view of the fact that iron levels decline during the course
of T. brucei infection [3], deprivation of iron from erythro-
poiesis could result in functional iron deficiency, a character-
istic feature of anemia of inflammation [2]. Furthermore, not
only myeloid cells can acquire iron via erythrophagocytosis or
uptake of iron-containing compounds, but also immature RBC
require iron. Since immature RBC represent the largest
percentage of all peripheral blood cells and express a Tf-R1,
they can contribute to the observed reduced serum iron
levels during infection. Therefore, iron deprivation may affect
drastically erythropoiesis at the level of the bone marrow and
spleen. To this end, a comparison was made between infected
control and GBT mice, at the level of RBC production/
differentiation in the bone marrow and spleen. This was
performed via flow cytometry (as described in [29]) using
a marker set based on (i) the cell-surface erythroid-specific
Ter119 antigen and (ii) the transferrin receptor (CD71), which
is detected only on early erythroid precursors to specifically
detect (pro)erythroblasts [30]. First it was observed that the
total percentage of Ter119þ cells in the bone marrow was
significantly reduced in infected control mice ( p-value
<0.01), whereas this drop is less pronounced in infected GBT
animals (Fig. 3a). However, there was no significant difference
between both infected groups. Yet, when looking at the total
amount of RBC isolated, it seems that in both groups of
infected mice there is a significant drop in absolute RBC
number as compared to non-infected animals (Fig. 3b, p-value
<0.001). Interestingly, the total RBC number in GBT-infected
mice is significantly higher than in control-infected mice
( p-value <0.001). At the level of the spleen, the total
percentage of Ter119þ cells increased significantly ( p-value
<0.001) upon infection in both groups of mice (Fig. 3c). Here
again no significant difference was observed between both
infected groups. Also, when looking at the total RBC counts in
the spleen of both infected groups of mice it is apparent that
the absolute RBC numbers are greatly elevated as compared to
non-infected mice (Fig. 3d). By subsequently gating on the
Ter119þ cell and simultaneous immunostaining of erythro-
blasts with anti-Ter119 and anti-CD71 antibodies, two distinct
populations, i.e., immature (Ter119þCD71þ, upper gate) and
mature (Ter119þCD71, lower gate) RBC, can be identified as
described by Socolovsky et al. [31] (see Fig. 3e). This analysiswas performed at the level of the bone marrow, spleen and
blood of na€ıve, control and GBT-infected (day 18 p.i.) mice.
As shown in Table 1 and Fig. 4a, during infection there is
an impaired RBC erythrocyte differentiation/maturation in the
bone marrow of both infected control and GBT mice
compared to na€ıve mice as evidenced by the percentage as
well as the absolute numbers of Ter119þCD71 cells, which is
less pronounced in the infected GBT mice. Also, the
percentage as well as the absolute number of immature RBC is
significantly reduced during infection in control mice and less
pronounced in GBT mice (Fig. 4b). In the current study, we
also observed in both infected groups of mice spleen
enlargement (splenomegaly) and the accumulation of early
erythroblasts which might be the result of massive extra-
medullar erythropoiesis [29]. As shown in Table 1 and Fig. 4c,
in the spleen there are relatively more mature RBC produced/
present in infected GBT mice as compared to infected control
mice. Also, a massive increase in the relative amount of early
Ter119þCD71þ-expressing erythroblasts occurs in the spleens
of both infected mice groups, here again, the accumulation of
immature erythrocytes in control mice is more pronounced
than in the GBT mice (Fig. 4d). Finally, it was observed
that during infection the percentage of mature RBC
(Ter119þCD71-cells) in the blood is significantly reduced in
control mice ( p-value< 0.01), whereas in GBT mice the
percentage of mature RBC returns to that of naive mice
(Table 1). When looking at the absolute numbers of RBC the
same trend is observed, yet, it seems that also in the infected
GBT mice the numbers are still lower than that in naive
animals (Fig. 4e). Another connotation is that during infection
there are relatively more immature RBC (Ter119þCD71þ-
expressing erythroblasts) in the blood in control mice, which is
not occurring in GBT mice (Fig. 4f).
4. Discussion
Anemia is a well-established infection-associated immu-
nopathological feature of animal trypanosomiasis and the
degree of anemia is considered as a reliable indicator of the
severity of infection. In order to study potential molecular
mechanisms/pathways that may directly or indirectly mediate
trypanosomiasis-associated anemia a recently developed
murine model was adopted based on: T. brucei-infected
C57Bl/6 or mock-treated (i.e., control) mice that exhibit
a trypanosusceptible phenotype (i.e., trypanosusceptible
model) versus T. brucei-infected GBT C57Bl/6 mice having
a more trypanotolerant phenotype (i.e., trypanotolerant
model). Similar to the bovine model, we observed that the
susceptible mice exhibited severe anemia development,
whereas the tolerant mice exhibited significantly reduced
anemia levels. Analysis of the experimental model during the
chronic phase of anemia revealed a number of interlinkable
observations.
First, in accordance with previous investigations [24], the
serum levels of pro-inflammatory cytokines (TNF, IFN-g and
IL-6) are elevated in infected control mice and reduced in
GBT mice, whereas the IL-10 levels are significantly elevated
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Table 1
Percentage of mature RBC in bone marrow, spleen and blood of na€ıve, control
and GBT-infected mice (day 18 p.i.). In the Ter119þ gate, the percentages of
mature RBC (Ter119þCD71 cells) were determined as described in Fig. 3e.
Results shown are representative for 2 independent experiments using each
time 3 mice per group.
% Mature RBC Naive Control GBT
Bone marrow 18.02 2.0 5.47 1.8 12.41 2.3
Spleen 61.50 2.2 13.52 2.6 22.8 3.0
Blood 93.24 1.6 81.50 4.3 91.85 3.1
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observed in the ‘‘tolerant’’ mice, such mice showed no
reduction in serum iron levels (Fe2þ) or hemoglobin levels in
contrast to the susceptible animals. These observations parallel
the difference in T. brucei-associated anemia between both
groups of mice.
Secondly, since the decreased serum iron and hemoglobin
levels are indicative for an altered iron homeostasis as well as
impaired RBC production, these two aspects were further
investigated. The differences observed at the level of inflam-
matory immune response between both groups of mice were
also reflected at the level of genes involved in the iron
homeostasis. Indeed, gene expression levels of HO-1, DMT-1,
two crucial molecules involved in RBC catabolism and iron
transport, respectively, and documented to be up-regulated
during T. brucei infection [3], were found to be significantly
reduced in infected GBT mice compared to control mice.
Moreover, infected GBT mice exhibited reduced gene
expression levels of FHC, as compared to control mice. Given
that TNF and IL-6 were documented to be important inducers
of FHC (reviewed by Weiss et al. [2] and [32,33]), the reduced
levels of these two cytokines in GBT mice could contribute to
down-regulate the FHC gene expression. On the other hand,
though Weiss and co-workers have showed that IL-10 can
induce FHC induction [34], in their experimental setup the
IL-10 levels used were relatively higher than those recorded
here. Moreover, the induction of FHC gene expression might
rely on a subtle balance between TNF, IL-6 as well as IL-10.
Concerning FPN-1, its increased expression in infected GBT
mice could be a consequence of lower IFN-g levels, since
IFN-g was documented to suppress FPN-1 expression
(reviewed by Weiss et al. [2]). The observed differences
between infected control and GBT mice at the level of the iron
homeostasis should be interpreted with caution. Indeed,
alterations in the modulation of iron homeostasis could reflect
differences in uptake of senescent or damaged RBC as well as
iron-containing compounds. Yet, assessing the gene expres-
sion levels of several receptors involved in uptake of RBC or
iron-containing compounds during T. brucei infection revealed
that only the transferrin (Tf) receptor 1 (Tf-R1) expression
levels differed significantly between both groups of mice. In
particular, the Tf-R1 mRNA levels (although induced during
infection) were significantly lower in GBT mice as compared
to control mice. This observation may be due to differences in
inflammatory state between both mice groups, since it was
documented that inflammatory signals and IFN-g/LPS couldincrease Tf-R1 expression by activating NF-kB [35]. In this
context it is appropriate to mention that while serum LPS-
levels have been documented to be elevated during the
chronic phase of infection [36], the GPI-based treatment was
found to desensitise macrophages towards LPS and conse-
quently reduce the inflammatory signals [24]. Therefore, the
lower Tf-R1 levels observed in infected GBT animals might be
attributed to a reduced response towards inflammatory stimuli.
The ubiquitously expressed Tf-R1 supplies body cells with
iron by internalisation of serum Tf, and interestingly, the Tf
expression levels, which were significantly reduced during
infection in control mice (Fig. 2b, left panel), were unaffected
in GBT mice.
Third, systemic iron homeostasis requires communication
between cells that need iron (mainly erythroid precursors) and
cells that acquire (duodenal enterocytes), store (hepatocytes
and tissue macrophages), or recycle (tissue macrophages) iron.
Since erythropoiesis increases in response to anemia, most of
the available iron will be used for the generation of new RBC.
Therefore, ‘iron withholding’ from erythroid progenitor cells
results in reduced erythropoiesis (reduced He synthesis)
[37,38], a decreased life span of iron-deficient RBC [39] and
a reduced global oxygen transport capacity [40], leading to
anemia. Of note, the problems at the level of erythropoiesis
were also suggested by several other groups [19,41,42]. Our
results support the idea that a reduced iron bio-availability
parallels an inefficient erythropoiesis in the bone marrow.
Additionally, infection/inflammation-induced splenomegaly
and extramedullar erythropoiesis occurs (stress-induced
erythropoiesis) which will aid in compensating for the extra
RBC demand [43]. These spleen progenitors exhibit properties
that are distinct from bone marrow erythroid progenitors,
suggesting that they represent a population of ‘‘stress erythroid
progenitors’’ resident in the spleen whose function is to rapidly
generate erythrocytes at times of great erythropoietic need
[44]. Our results indicate that indeed during infection extra-
medullar erythropoiesis occurs as evidenced by the increased
amount of total RBC in infected animals. Yet, the percentage
of mature RBC is significantly higher in GBT mice as
compared to control mice, indicating that there seem to be
problems of RBC maturation during infection. This inefficient
erythropoiesis was also observed in ceruloplasmin-deficient
(Cp/) mice subjected to phenylhydrazine-induced hemo-
lytic anemia where the mice also exhibited impaired recovery
from anemia due to defective iron transport [45]. Cp is needed
for loading of iron onto Tf and interestingly Cp levels were
also reduced during T. brucei infection [5]. Thus, loading of
iron onto Tf as well as reduced Tf expression levels might both
impair iron transport to bone marrow and spleen. It is
furthermore conceivable that impaired RBC maturation could
be a consequence of inflammatory cytokines like TNF and
IFN-g, which were shown to suppress erythropoiesis by
inducing the death of hematopoietic progenitor cells through
increased apoptosis [46e48]. Furthermore, the reduced TNF
levels observed in the tolerant model could also contribute to
a reduced senescence and consequently clearance of RBC
[49]. Reducing the inflammatory state by the GPI-based
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Fig. 4. Absolute mature and immature RBC counts of bone marrow, spleen and blood. Determination of absolute mature RBC numbers (Ter119þCD71 cells) in
the bone marrow (A), spleen (C) and blood (E) of na€ıve (black bar), control (white bar) and GBT- (gray bar) infected mice (day 18 p.i.). Determination of absolute
immature RBC numbers (Ter119þCD71þ cells) in the bone marrow (B), spleen (D) and blood (F) of na€ıve (black bar), control (white bar) and GBT- (gray bar)
infected mice (day 18 p.i.). The absolute numbers of mature and immature RBC of the bone marrow and spleen were calculated from the total number of RBC (see
Fig. 3b and d) and the percentages shown in Table 1. The absolute numbers of mature and immature RBC of the blood were determined from the absolute RBC
numbers used to generate Fig. 1a and the percentages shown in Table 1. Results shown are representative for 2 independent experiments using each time 3 mice per
group. (*: p-values 0.05, **: p-value 0.01).
397B. Stijlemans et al. / Microbes and Infection 12 (2010) 389e399treatment resulted in an increased RBC maturation both in the
spleen and the bone marrow as evidenced by the higher
Ter119þCD71 cell percentages. This coincided with
increased Tf expression levels as well as serum iron levels in
GBT mice. Collectively, a possible explanation for the anemiadevelopment during infection might be a combination of
several factors: (i) due to the inflammation there is iron
accumulation inside the macrophages resulting in a depriva-
tion for erythropoiesis, (ii) due to the reduced Tf expression
there might be insufficient supply of iron needed for
398 B. Stijlemans et al. / Microbes and Infection 12 (2010) 389e399erythropoiesis at the level of the bone marrow and/or spleen,
(iii) the expansion of immature RBC in the spleen, expressing
the Tf-R1 could contribute to the reduced serum iron levels
and (iv) a combination of inflammatory cytokines and other
host factors that might be induced due to inflammation can
suppress erythropoiesis. Thus, the use of this GPI-based
intervention strategy to reduce the inflammatory state of
macrophages (or reprogramming macrophages) represents an
as yet unexplored interesting tool to study ACD and might
reveal new potential treatment strategies for inflammation
associated pathologies like anemia of inflammation. There-
fore, this GPI-based treatment, i.e., trypanotolerant model,
might aid to identify target molecules involved in persistence
of inflammation as well as suppression of erythropoiesis and
could represent a suitable tool to study the ACD during
African trypanosomiasis. The results obtained here using the
GPI-based treatment indicates that erythropoiesis is affected
by the inflammatory state of the macrophages and provide
evidence that there is a problem of RBC maturation during
African trypanosomiasis.
Acknowledgments
This work was supported by the kind technical assistance of
Ella Omasta and Marie-The´re`se Detobel. The authors have no
conflicting financial interests.
References
[1] G. Weiss, Modification of iron regulation by the inflammatory response.
Best Pract. Res. Clin. Haematol. 18 (2005) 183e201.
[2] G. Weiss, L.T. Goodnough, Anemia of chronic disease. N. Engl. J. Med.
352 (2005) 1011e1023.
[3] B. Stijlemans, A. Vankrunkelsven, L. Brys, S. Magez, P. De Baetselier,
Role of iron homeostasis in trypanosomiasis-associated anemia.
Immunobiology 213 (2008) 823e835.
[4] S.C. Welburn, E.M. Fevre, P.G. Coleman, M. Odiit, I. Maudlin, Sleeping
sickness: a tale of two diseases. Trends Parasitol. 17 (2001) 19e24.
[5] M.P. Barrett, R.J. Burchmore, A. Stich, J.O. Lazzari, A.C. Frasch, J.J.
Cazzulo, S.Krishna, The trypanosomiases. Lancet 362 (2003) 1469e1480.
[6] G.D. d’Ieteren, E. Authie, N. Wissocq, M. Murray, Trypanotolerance, an
option for sustainable livestock production in areas at risk from trypa-
nosomosis. Rev. Sci. Tech. 17 (1998) 154e175.
[7] M. Murray, W.I. Morrison, D.D. Whitelaw, Host susceptibility to African
trypanosomiasis: trypanotolerance. Adv. Parasitol. 21 (1982) 1e68.
[8] M. Murray, T.M. Dexter, Anaemia in bovine African trypanosomiasis.
A review. Acta Trop. 45 (1988) 389e432.
[9] J. Naessens, Bovine trypanotolerance: a natural ability to prevent severe
anaemia and haemophagocytic syndrome? Int. J. Parasitol. 36 (2006)
521e528.
[10] S. Magez, A. Schwegmann, R. Atkinson, F. Claes, M. Drennan, P. De
Baetselier, F. Brombacher, The role of B-cells and IgM antibodies in
parasitemia, anemia, and VSG switching in Trypanosoma brucei-infected
mice. PLoS Pathog. 4 (2008) e1000122.
[11] S. Magez, C. Truyens, M. Merimi, M. Radwanska, B. Stijlemans, P.
Brouckaert, F. Brombacher, E. Pays, P. De Baetselier, P75 tumor necrosis
factorereceptor shedding occurs as a protective host response during
African trypanosomiasis. J. Infect. Dis. 189 (2004) 527e539.
[12] Y. Nakamura, J. Naessens, M. Takata, T. Taniguchi, K. Sekikawa, J.
Gibson, F. Iraqi, Susceptibility of heat shock protein 70.1-deficient
C57BL/6 J, wild-type C57BL/6 J and A/J mice to Trypanosoma
congolense infection. Parasitol. Res. 90 (2003) 171e174.[13] S. Magez, M. Radwanska, A. Beschin, K. Sekikawa, P. De Baetselier,
Tumor necrosis factor alpha is a key mediator in the regulation of
experimental Trypanosoma brucei infections. Infect. Immun. 67 (1999)
3128e3132.
[14] M.B. Drennan, B. Stijlemans, J. Van den Abbeele, V.J. Quesniaux, M.
Barkhuizen, F. Brombacher, P. De Baetselier, B. Ryffel, S. Magez, The
induction of a type 1 immune response following a Trypanosoma brucei
infection is MyD88 dependent. J. Immunol. 175 (2005) 2501e2509.
[15] S. Magez, B. Stijlemans, G. Caljon, H.P. Eugster, P. De Baetselier,
Control of experimental Trypanosoma brucei infections occurs inde-
pendently of lymphotoxinealpha induction. Infect. Immun. 70 (2002)
1342e1351.
[16] V.O. Anosa, J.J. Kaneko, Pathogenesis of Trypanosoma brucei infection
in deer mice (Peromyscus maniculatus): light and electron microscopic
studies on erythrocyte pathologic changes and phagocytosis. Am. J. Vet.
Res. 44 (1983) 645e651.
[17] M. Shi, G. Wei, W. Pan, H. Tabel, Trypanosoma congolense infections:
antibody-mediated phagocytosis by Kupffer cells. J. Leukoc. Biol. 76
(2004) 399e405.
[18] M. Shi, G. Wei, W. Pan, H. Tabel, Impaired Kupffer cells in highly
susceptible mice infected with Trypanosoma congolense. Infect. Immun.
73 (2005) 8393e8396.
[19] A.G. Andrianarivo, P. Muiya, L.L. Logan-Henfrey, Trypanosoma
congolense: high erythropoietic potential in infected yearling cattle
during the acute phase of the anemia. Exp. Parasitol. 82 (1996) 104e111.
[20] J.J. Buza, L. Logan-Henfrey, A.G. Andrianarivo, D.J. Williams, Rise in
erythropoietin concentrations in experimental Trypanosoma congolense
infection of calves. J. Comp. Pathol. 113 (1995) 343e356.
[21] M. Sileghem, R. Saya, D.J. Grab, J. Naessens, An accessory role for the
diacylglycerol moiety of variable surface glycoprotein of African
trypanosomes in the stimulation of bovine monocytes. Vet. Immunol.
Immunopathol. 78 (2001) 325e339.
[22] S.D. Tachado, L. Schofield, Glycosylphosphatidylinositol toxin of
Trypanosoma brucei regulates IL-1 alpha and TNF-alpha expression in
macrophages by protein tyrosine kinase mediated signal transduction.
Biochem. Biophys. Res. Commun. 205 (1994) 984e991.
[23] S. Magez, B. Stijlemans, M. Radwanska, E. Pays, M.A. Ferguson, P. De
Baetselier, The glycosyl-inositol-phosphate and dimyristoylglycerol
moieties of the glycosylphosphatidylinositol anchor of the trypanosome
variant-specific surface glycoprotein are distinct macrophage-activating
factors. J. Immunol. 160 (1998) 1949e1956.
[24] B. Stijlemans, T.N. Baral, M. Guilliams, L. Brys, J. Korf, M. Drennan, J.
Van Den Abbeele, P. De Baetselier, S. Magez, A glycosylphos
phatidylinositol-based treatment alleviates trypanosomiasis-associated
immunopathology. J. Immunol. 179 (2007) 4003e4014.
[25] S. Magez, B. Stijlemans, T. Baral, P. De Baetselier, VSG-GPI anchors of
African trypanosomes: their role in macrophage activation and induction
of infection-associated immunopathology. Microbes. Infect. 4 (2002)
999e1006.
[26] G. Raes, L. Brys, B.K. Dahal, J. Brandt, J. Grooten, F. Brombacher,
G. Vanham, W. Noel, P. Bogaert, T. Boonefaes, A. Kindt, R. Van den
Bergh, P.J. Leenen, P. De Baetselier, G.H. Ghassabeh, Macrophage
galactose-type C-type lectins as novel markers for alternatively activated
macrophages elicited by parasitic infections and allergic airway inflam-
mation. J. Leukoc. Biol. 77 (2005) 321e327.
[27] K.D. Poss, S. Tonegawa, Heme oxygenase 1 is required for mammalian
iron reutilization. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10919e10924.
[28] F.H. Bach, Heme oxygenase-1 as a protective gene. Wien. Klin.
Wochenschr. 114 (Suppl. 4) (2002) 1e3.
[29] T. Kina, K. Ikuta, E. Takayama, K. Wada, A.S. Majumdar,
I.L.Weissman, Y. Katsura, The monoclonal antibody TER-119 recognizes
a molecule associated with glycophorin A and specifically marks the late
stages of murine erythroid lineage. Br. J. Haematol. 109 (2000) 280e287.
[30] C.N. Lok, P. Ponka, Identification of an erythroid active element in the
transferrin receptor gene. J. Biol. Chem. 275 (2000) 24185e24190.
[31] M. Socolovsky, H. Nam, M.D. Fleming, V.H. Haase, C. Brugnara, H.F.
Lodish, Ineffective erythropoiesis in Stat5a(/)5b(/) mice due to
decreased survival of early erythroblasts. Blood 98 (2001) 3261e3273.
399B. Stijlemans et al. / Microbes and Infection 12 (2010) 389e399[32] Y. Tsuji, L.L. Miller, S.C. Miller, S.V. Torti, F.M. Torti, Tumor necrosis
factor-alpha and interleukin 1-alpha regulate transferrin receptor in
human diploid fibroblasts. Relationship to the induction of ferritin heavy
chain. J. Biol. Chem. 266 (1991) 7257e7261.
[33] L.L. Miller, S.C. Miller, S.V. Torti, Y. Tsuji, F.M. Torti, Iron-independent
induction of ferritin H chain by tumor necrosis factor. Proc. Natl. Acad.
Sci. U. S. A. 88 (1991) 4946e4950.
[34] H. Tilg, H. Ulmer, A. Kaser, G. Weiss, Role of IL-10 for induction of
anemia during inflammation. J. Immunol. 169 (2002) 2204e2209.
[35] L. Tacchini, E. Gammella, C. De Ponti, S. Recalcati, G. Cairo, Role of
HIF-1 and NF-kappa B transcription factors in the modulation of trans-
ferrin receptor by inflammatory and anti-inflammatory signals. J. Biol.
Chem. 283 (2008) 20674e20686.
[36] V.W. Pentreath, Endotoxins and their significance for murine trypano-
somiasis. Parasitol. Today 10 (1994) 226e229.
[37] C. Brugnara, Iron deficiency and erythropoiesis: new diagnostic
approaches. Clin. Chem. 49 (2003) 1573e1578.
[38] U. Arndt, J.P. Kaltwasser, R. Gottschalk, D. Hoelzer, B. Moller,
Correction of iron-deficient erythropoiesis in the treatment of anemia of
chronic disease with recombinant human erythropoietin. Ann. Hematol.
84 (2005) 159e166.
[39] D.S. Kempe, P.A. Lang, C. Duranton, A. Akel, K.S. Lang, S.M. Huber,
T. Wieder, F. Lang, Enhanced programmed cell death of iron-deficient
erythrocytes. FASEB J. 20 (2006) 368e370.
[40] G.R.Lee,The anemiaof chronic disease. Semin.Hematol. 20 (1983) 61e80.
[41] A.O. Ogunsanmi, S.O. Akpavie, V.O. Anosa, Haematological changes in
ewes experimentally infected with Trypanosoma brucei. Rev. Elev. Med.
Vet. Pays. Trop. 47 (1994) 53e57.[42] I.O. Igbokwe, Dyserythropoiesis in animal trypanosomosis. Rev. Elev.
Med. Vet. Pays. Trop. 42 (1989) 423e429.
[43] M. Obinata, N. Yanai, Cellular and molecular regulation of an erythro-
poietic inductive microenvironment (EIM). Cell. Struct. Funct. 24 (1999)
171e179.
[44] L.E. Lenox, J.M. Perry, R.F. Paulson, BMP4 and Madh5 regulate the
erythroid response to acute anemia. Blood 105 (2005) 2741e2748.
[45] S. Cherukuri, N.A. Tripoulas, S. Nurko, P.L. Fox, Anemia and impaired
stress-induced erythropoiesis in aceruloplasminemic mice. Blood Cells
Mol. Dis. 33 (2004) 346e355.
[46] E.J. Kanfer, C.M. Price, A.A. Gordon, A.J. Barrett, The in vitro
effects of interferon-gamma, interferon-alpha, and tumour necrosis
factor-alpha on erythroid burst-forming unit growth in patients with
non-leukaemic myeloproliferative disorders. Eur. J. Haematol. 50
(1993) 250e254.
[47] C. Dufour, A. Corcione, J. Svahn, R. Haupt, V. Poggi, A.N. Beka’ssy,
R. Scime, A. Pistorio, V. Pistoia, TNF-alpha and IFN-gamma are
overexpressed in the bone marrow of Fanconi anemia patients and
TNF-alpha suppresses erythropoiesis in vitro. Blood 102 (2003)
2053e2059.
[48] N. Felli, F. Pedini, A. Zeuner, E. Petrucci, U. Testa, C. Conticello, M.
Biffoni, A. Di Cataldo, J.A. Winkles, C. Peschle, R. De Maria, Multiple
members of the TNF superfamily contribute to IFN-gamma-mediated
inhibition of erythropoiesis. J. Immunol. 175 (2005) 1464e1472.
[49] L.L. Moldawer, M.A. Marano, H. Wei, Y. Fong, M.L. Silen, G. Kuo, K.
R. Manogue, H. Vlassara, H. Cohen, A. Cerami, Cachectin/tumor
necrosis factor-alpha alters red blood cell kinetics and induces anemia in
vivo. FASEB J. 3 (1989) 1637e1643.
